Innovative use of hydrogel technology to recapitulate and investigate cardiac pathology. [ 2018 - 2021 ]

Research Grant

Researchers: Dr Helena Viola (Principal investigator)

Brief description Hypertrophic cardiomyopathy is the leading cause of sudden death in the young. No treatment exists that can reverse or prevent it, primarily because the underlying mechanisms of the disease have not been fully elucidated. I will use innovative hydrogel technology to simulate the disease state. I will use this as a tool to identify the mechanisms involved with development of the disease. This will enable identification of potential therapeutic targets for prevention of the disease.

Funding Amount $AUD 726,188.28

Funding Scheme Project Grants

Notes New Investigator Grant